PMcardio receives FDA Breakthrough Device Designation — read the full story

PM Magazine

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.

Editor's Choice

Winners+of+AHA's+Health+Tech+Competition+2024

Powerful Medical Wins Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024

Timothy D. Henry, MD joins Powerful Medical's US Scientific board

Timothy D. Henry, MD Joins Powerful Medical’s US Scientific Advisory Board Amidst Entry to the US Market

Jolimont Hospital Helora

Jolimont Hospital in Belgium Implements PMcardio AI to Detect Acute Myocardial Infarction

ECG Interpretation Tools Compared – Why PMcardio Stands Out

Interpreting ECGs accurately and swiftly is essential for clinicians at every frontline patient encounter—from primary care to emergency settings. Choosing the appropriate interpretation tool significantly impacts patient outcomes. Today, we explore three accessible solutions for clinicians: Conventional ECG Algorithms, General AI language models like ChatGPT, and PMcardio.

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.

ECGxplain™: The Explainability Feature in PMcardio -With Human-Centered Design in Mind

In high-stakes emergency and cath lab settings, every second counts when diagnosing acute myocardial infarctions. PMcardio’s Explainability feature brings unmatched transparency to AI-powered ECG analysis, empowering clinicians with clear, trustworthy insights for faster, more confident decision-making.
Jolimont Hospital Helora

Jolimont Hospital in Belgium Implements PMcardio AI to Detect Acute Myocardial Infarction

Jolimont Hospital, a flagship institution within the HELORA network, has successfully implemented the AI-powered clinical care coordination platform PMcardio.

Stay on the pulse with our newsletter

Your submission was successful